Dr Fenske on ASCT Outcomes in MCL After First MRD-Negative CR

Timothy S. Fenske, MD, MS, professor of Medicine, the Medical College of Wisconsin, shares an initial report of the randomized, phase 3 ECOG-ACRIN EA4151 trial (NCT03267433), evaluating the use of autologous stem cell transplant in patients with mantle cell lymphoma with undetectable minimal residual disease following first complete remission. Fenske and colleagues shared these results in a presentation at the 2024 ASH Annual Meeting.